Development of an immunologically tolerated combination of fluorescent proteins for in vivo two-photon imaging

Selamawit Gossa1, Debasis Nayak1, Bernd H Zinselmeyer1

  • 1National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.

Scientific Reports
|October 18, 2014
PubMed

Combinations of fluorescent proteins (FPs) are routinely used for multi-parameter in vivo imaging experiments to visualize tagged proteins or cell populations of interest. Studies involving FPs are often limited by spectral overlap, toxicity, relative quantum efficiency, and the potential for immunological rejection upon transfer into a non-tolerant recipient. Here we evaluate the immunologic visibility of several commonly used FPs by the murine immune system and identify a spectrally compatible, immunologically tolerated combination of FPs well suited for in vivo two-photon imaging.

Related Concept Videos